MREO and 0A9G Related Headlines
Go Back- Mereo BioPharma strikes alvelestat licensing deal with Sentynl for U.S. rights
- Sentynl Therapeutics and Mereo BioPharma Announce Option and License Agreement for alvelestat in Alpha-1 Antitrypsin Deficiency-Associated Lung Disease (AATD-LD)
- Aura Biosciences adds former Day One CEO to its board
- Aura Biosciences Announces Appointment of Jeremy Bender, Ph.D., M.B.A., to Board of Directors
- 4basebio appoints Richard Bungay as CFO, announces board changes
- 4basebio Announces Appointment of Chief Financial Officer and Board Changes
- Mereo BioPharma Group plc Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - MREO
- MREO Shareholder Alert: April 6, 2026 Lead Plaintiff Deadline in Mereo BioPharma Group plc Securities Class Action Lawsuit -- The Gross Law Firm
- Portnoy Law Firm Announces Class Action on Behalf of Mereo BioPharma Group plc Investors
- MREO Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in Mereo BioPharma Group plc Securities Lawsuit — The Gross Law Firm
- Mereo BioPharma Group plc Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - MREO
- Class Action Filed Against Mereo BioPharma Group plc (MREO) - April 6, 2026 Deadline to Join - Contact The Gross Law Firm
- Portnoy Law Firm Announces Class Action on Behalf of Mereo BioPharma Group plc Investors
- Mereo BioPharma Group plc Class Action: The Gross Law Firm Reminds Mereo Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of April 6, 2026 – MREO
- The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of April 6, 2026 in Mereo Lawsuit - MREO
- Portnoy Law Firm Announces Class Action on Behalf of Mereo BioPharma Group plc Investors
- MREO Investors Have Opportunity to Lead Mereo BioPharma Group plc Securities Fraud Lawsuit with the Schall Law Firm
- Mereo BioPharma Group plc Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - MREO
- Mereo BioPharma Group plc Class Action: The Gross Law Firm Reminds Mereo Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of April 6, 2026 – MREO
- Portnoy Law Firm Announces Class Action on Behalf of Mereo BioPharma Group plc Investors
- The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of April 6, 2026 in Mereo BioPharma Group plc Lawsuit - MREO
- Holzer & Holzer, LLC Reminds MREO Investors of the April 6, 2026 Lead Plaintiff Deadline in the Mereo BioPharma Group plc Securities Class Action
- Mereo BioPharma Group plc Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - MREO
- MREO Investors Have Opportunity to Lead Mereo BioPharma Group plc Securities Fraud Lawsuit with the Schall Law Firm
- MREO Investors Have Opportunity to Lead Mereo BioPharma Group plc Securities Fraud Lawsuit with the Schall Law Firm
- Portnoy Law Firm Announces Class Action on Behalf of Mereo BioPharma Group plc Investors
- Mereo BioPharma Group plc Sued for Securities Law Violations – Investors Should Contact The Gross Law Firm for More Information – MREO
- Holzer & Holzer, LLC Reminds MREO Investors of the April 6, 2026 Lead Plaintiff Deadline in the Mereo BioPharma Group plc Securities Class Action
- MREO Investors Have Opportunity to Lead Mereo BioPharma Group plc Securities Fraud Lawsuit with the Schall Law Firm
MREO and 0A9G Related Press Releases
Go Back- Sentynl Therapeutics and Mereo BioPharma Announce Option and License Agreement for alvelestat in Alpha-1 Antitrypsin Deficiency-Associated Lung Disease (AATD-LD)
- Aura Biosciences Announces Appointment of Jeremy Bender, Ph.D., M.B.A., to Board of Directors
- 4basebio Announces Appointment of Chief Financial Officer and Board Changes
- Mereo BioPharma Group plc Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - MREO
- MREO Shareholder Alert: April 6, 2026 Lead Plaintiff Deadline in Mereo BioPharma Group plc Securities Class Action Lawsuit -- The Gross Law Firm
- Portnoy Law Firm Announces Class Action on Behalf of Mereo BioPharma Group plc Investors
- MREO Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in Mereo BioPharma Group plc Securities Lawsuit — The Gross Law Firm
- Mereo BioPharma Group plc Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - MREO
- Class Action Filed Against Mereo BioPharma Group plc (MREO) - April 6, 2026 Deadline to Join - Contact The Gross Law Firm
- Portnoy Law Firm Announces Class Action on Behalf of Mereo BioPharma Group plc Investors
- Mereo BioPharma Group plc Class Action: The Gross Law Firm Reminds Mereo Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of April 6, 2026 – MREO
- The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of April 6, 2026 in Mereo Lawsuit - MREO
- Portnoy Law Firm Announces Class Action on Behalf of Mereo BioPharma Group plc Investors
- MREO Investors Have Opportunity to Lead Mereo BioPharma Group plc Securities Fraud Lawsuit with the Schall Law Firm
- Mereo BioPharma Group plc Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - MREO
- Mereo BioPharma Group plc Class Action: The Gross Law Firm Reminds Mereo Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of April 6, 2026 – MREO
- Portnoy Law Firm Announces Class Action on Behalf of Mereo BioPharma Group plc Investors
- The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of April 6, 2026 in Mereo BioPharma Group plc Lawsuit - MREO
- Holzer & Holzer, LLC Reminds MREO Investors of the April 6, 2026 Lead Plaintiff Deadline in the Mereo BioPharma Group plc Securities Class Action
- Mereo BioPharma Group plc Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - MREO
- MREO Investors Have Opportunity to Lead Mereo BioPharma Group plc Securities Fraud Lawsuit with the Schall Law Firm
- MREO Investors Have Opportunity to Lead Mereo BioPharma Group plc Securities Fraud Lawsuit with the Schall Law Firm
- Portnoy Law Firm Announces Class Action on Behalf of Mereo BioPharma Group plc Investors
- Mereo BioPharma Group plc Sued for Securities Law Violations – Investors Should Contact The Gross Law Firm for More Information – MREO
- Holzer & Holzer, LLC Reminds MREO Investors of the April 6, 2026 Lead Plaintiff Deadline in the Mereo BioPharma Group plc Securities Class Action
- MREO Investors Have Opportunity to Lead Mereo BioPharma Group plc Securities Fraud Lawsuit with the Schall Law Firm
MREO and 0A9G Related SEC Filings
Go Back- Form 8-K Mereo BioPharma Group For: Aug 18
- Form SCHEDULE 13G/A Mereo BioPharma Group Filed by: EcoR1 Capital, LLC
- Form 10-Q Mereo BioPharma Group For: Jun 30
- Form 8-K Mereo BioPharma Group For: Aug 11
- Form 8-K Mereo BioPharma Group For: Aug 11
- Form SCHEDULE 13G/A Mereo BioPharma Group Filed by: EcoR1 Capital, LLC
- Form SCHEDULE 13G Mereo BioPharma Group Filed by: BANK OF AMERICA CORP /DE/
- Form 8-K Mereo BioPharma Group For: May 14
- Form 8-K/A Mereo BioPharma Group For: May 12
- Form 10-Q Mereo BioPharma Group For: Mar 31
- Form 8-K Mereo BioPharma Group For: May 12
- Form ARS Mereo BioPharma Group For: Dec 31
- Form DEF 14A Mereo BioPharma Group For: Apr 08
- Form PRE 14A Mereo BioPharma Group For: Mar 27
- Form 8-K Mereo BioPharma Group For: Mar 26
- Form 10-K Mereo BioPharma Group For: Dec 31
- Form 8-K Mereo BioPharma Group For: Mar 19
- Form 4 Mereo BioPharma Group For: Feb 26 Filed by: Jenkins Annalisa
- Form 4 Mereo BioPharma Group For: Feb 26 Filed by: Jacquet Pierre
- Form 4 Mereo BioPharma Group For: Feb 26 Filed by: Bender Jeremy
- Form 4 Mereo BioPharma Group For: Feb 26 Filed by: PAKIANATHAN DEEPIKA
- Form 4 Mereo BioPharma Group For: Feb 26 Filed by: Ekblom Anders
- Form 4 Mereo BioPharma Group For: Feb 26 Filed by: Yoskowitz Marc J
- Form 4 Mereo BioPharma Group For: Feb 26 Filed by: WYZGA MICHAEL S
- Form 4 Mereo BioPharma Group For: Feb 26 Filed by: Shames Daniel
- Form SCHEDULE 13G/A Mereo BioPharma Group Filed by: Northpond Ventures, LP
- Form 8-K Mereo BioPharma Group For: Feb 17
- Form SCHEDULE 13G/A Mereo BioPharma Group Filed by: JANUS HENDERSON GROUP PLC
- Form SCHEDULE 13G/A Mereo BioPharma Group Filed by: Frazier Life Sciences Public Fund, L.P.
- Form 4 Mereo BioPharma Group For: Feb 01 Filed by: Scots-Knight Denise
- Form 4 Mereo BioPharma Group For: Feb 01 Filed by: Lewicki John A.
- Form 4 Mereo BioPharma Group For: Feb 01 Filed by: Sermon Charles
- Form 4 Mereo BioPharma Group For: Feb 01 Filed by: Fox Christine Ann
- Form 4 Mereo BioPharma Group For: Feb 01 Filed by: Hughes-Wilson Alexandra
- Form S-8 Mereo BioPharma Group
- Form 8-K Mereo BioPharma Group For: Jan 12
- Form SCHEDULE 13G Mereo BioPharma Group Filed by: EcoR1 Capital, LLC
- Form SCHEDULE 13G Mereo BioPharma Group Filed by: 683 Capital Management, LLC
- Form 8-K Mereo BioPharma Group For: Dec 29
- Form SCHEDULE 13G/A Mereo BioPharma Group Filed by: JANUS HENDERSON GROUP PLC
- Form SCHEDULE 13G/A Mereo BioPharma Group Filed by: MANGROVE PARTNERS IM, LLC
- Form 8-K Mereo BioPharma Group For: Nov 10
- Form 10-Q Mereo BioPharma Group For: Sep 30
